EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Healthcare utilization during acute medically attended episodes of respiratory syncytial virus-related lower respiratory tract infection among infants in the United States

Jason R Gantenberg iD, Robertus van Aalst iD, David R Diakun, Angela M Bengtson, Brendan L Limone, Christopher B Nelson, David A Savitz, Andrew R Zullo

PLOS ONE · 2025

DOI: 10.1371/journal.pone.0313573 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2025. Verfasst von Jason R Gantenberg und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Services, Policy & Practice, Brown University School of Public Health, Providence, Rhode Island, United States of America. Hauptthemen laut MEDLINE: Respiratory Syncytial Virus Infections, Patient Acceptance of Health Care, Respiratory Tract Infections. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sanofi, AstraZeneca.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Respiratory syncytial virus (RSV) is the leading cause of infant hospitalization in the United States. Understanding healthcare utilization associated with medically attended (MA) RSV lower respiratory tract infection (LRTI) might inform research priorities aimed at reducing RSV-associated pediatric morbidity. We described healthcare utilization during acute MA RSV LRTI episodes within a geographically diverse cohort of infants in the United States.

Methods

We created retrospective cohorts of infants born in the United States from July 1, 2016 through February 29, 2020 in each of three de-identified insurance claims datasets: Merative MarketScan Commercial Claims and Encounters, Multi-State MarketScan Medicaid, and Optum’s de-identified Clinformatics ® Data Mart. We identified infants’ first MA RSV LRTI diagnosis during their first RSV season and followed them for 7 subsequent days to record outpatient, emergency department, and inpatient hospital utilization. We calculated the number of outpatient visits, emergency department visits, and inpatient hospital stays occurring during this acute episode and estimated the proportion of episodes involving ≥ 2 visits to a given healthcare setting.

Results

In the CCAE database, we identified 25,409 acute MA RSV LRTI episodes under the specific RSV definition and 69,068 under the sensitive definition. In the MDCD database, these totals were 67,357 and 170,744, while in the CDM database, they were 12,402 and 31,363, respectively. Across data sources, 34%–69% of infants’ first acute MA RSV LRTI episodes involve 2 or more visits to a healthcare setting within 7 days. The percentage of episodes involving at least 2 visits ranged from 34–62% among healthy term infants, 38–65% for Palivizumab-eligible infants, and 38–69% for infants with other comorbidities.

Conclusions

Within a week of their first MA RSV LRTI diagnosis, infants frequently experience at least 2 visits to one or more healthcare settings, regardless of their comorbidity profile. The percentage of MA RSV LRTI episodes involving at least 2 visits to a healthcare setting may vary by insurance claims database, even between commercial payers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Respiratory Syncytial Virus InfectionsPatient Acceptance of Health CareRespiratory Tract InfectionsHumansUnited StatesInfantRetrospective StudiesMaleFemaleHospitalizationInfant, NewbornEmergency Service, HospitalRespiratory Syncytial Virus, HumanAcute Disease

Autor:innen und Institutionen

  • Department of Health Services, Policy & Practice, Brown University School of Public Health, Providence, Rhode Island, United States of America.
  • Department of Epidemiology, Brown University School of Public Health, Providence, Rhode Island, United States of America.
  • New Products and Innovation Franchise, Vaccines Medical Affairs Sanofi, Lyon, France.
  • Department of Health Sciences, University Medical Center Groningen, Groningen, The Netherlands.
  • Merative, Ann Arbor, Michigan, United States of America.
  • Vaccines Medical Affairs, Sanofi, Swiftwater, Pennsylvania, United States of America.

ORCID-Profile: Jason R Gantenberg, Robertus van Aalst

Förderung

  • Sanofi
  • AstraZeneca

Zitieren

APA

Gantenberg, J. R., van Aalst, R., Diakun, D. R., Bengtson, A. M., Limone, B. L., Nelson, C. B., Savitz, D. A., & Zullo, A. R. (2025). Healthcare utilization during acute medically attended episodes of respiratory syncytial virus-related lower respiratory tract infection among infants in the United States. PLOS ONE. https://doi.org/10.1371/journal.pone.0313573

Vancouver

Gantenberg JR, van Aalst R, Diakun DR, Bengtson AM, Limone BL, Nelson CB, et al. Healthcare utilization during acute medically attended episodes of respiratory syncytial virus-related lower respiratory tract infection among infants in the United States. PLOS ONE. 2025. doi:10.1371/journal.pone.0313573

BibTeX
@article{Gantenberg2025,
  author = {Gantenberg, Jason R and van Aalst, Robertus and Diakun, David R and Bengtson, Angela M and Limone, Brendan L and Nelson, Christopher B and Savitz, David A and Zullo, Andrew R},
  title = {Healthcare utilization during acute medically attended episodes of respiratory syncytial virus-related lower respiratory tract infection among infants in the United States},
  journal = {PLOS ONE},
  year = {2025},
  doi = {10.1371/journal.pone.0313573}
}
Kostenlos starten →